ATTD Yearbook Session, ATTD 2026 Conference Catch-Up

In this episode of ATTD 2026 Conference Catch-Up, we dive into the Scientific Plenary Session: ATTD Yearbook Session, featuring a comprehensive overview of the most important advances in diabetes technology, treatments, and care over the past year. Join us as we summarize key takeaways from these thought-provoking presentations: • Continuous and Intermittent Glucose Monitoring – Professor Jennifer Sherr (United States of America) • Insulin Delivery Hardware: Pumps and Pens – Dr. Rayhan Lal (United States of America) • New Insulins, Biosimilars and Insulin Therapy – Dr. Torben Biester (Germany) • Closed-Loop, Decision Support, and Artificial Intelligence – Dr. Mark Clements (United States of America) examines advances in automated insulin delivery systems and AI-supported diabetes management. • Using Digital Health Technology to Prevent and Treat Diabetes – Dr. Neal Kaufman highlights the expanding role of digital tools in diabetes prevention and care. • Technology and Pregnancy – Jennifer M. Yamamoto (Canada) reviews the use of diabetes technologies to support glucose management during pregnancy. • Diabetes Technology and Therapy in the Pediatric Age Group – Prof. David M. Maahs (United States of America) discusses technological and therapeutic advances in pediatric diabetes care. • Advances in Exercise and Nutrition as Therapy in Diabetes – Prof. Michael C. Riddell (Canada) explores the evolving role of lifestyle interventions supported by technology. • Primary Care and Diabetes Technologies and Treatments – Dr. Gregg D. Simonson (United States of America) examines how innovations in diabetes care are being integrated into primary care settings. • Use of Technologies at the Advanced Age – Dr. Anna Kahkoska (United States of America) discusses the challenges and opportunities of implementing diabetes technologies in older adults. • The Real “Real World”: Overcoming Practical Barriers and Disparities in Diabetes Technology – Dr. Ananta Addala (United States of America) highlights real-world challenges in access and implementation. • Diabetes Technology in the Hospital – Tim Hropot (Slovenia) reviews the role of diabetes technologies in inpatient care. • Impact of Diabetes Technologies on Psychosocial Outcomes – Alon Liberman (Israel) discusses how technological advances affect quality of life and psychosocial wellbeing. • Immune Intervention and Beta Cell Replacement Therapies in Type 1 Diabetes – Prof. Desmond Schatz (United States of America) reviews emerging therapeutic approaches aimed at modifying disease progression. • Obesity and Diabetes – Dr. Viral N. Shah (United States of America) examines the evolving relationship between obesity and diabetes management. • Emerging Trends in MASLD and MASH – Prof. Satish K. Garg (USA) explores new insights into metabolic liver disease and its links to diabetes. • Virtual Clinics for Diabetes Care – Prof. Satish K. Garg discusses the growing role of telemedicine and virtual care models. • New Medications for the Treatment of Diabetes – Prof. Satish K. Garg reviews emerging pharmacological therapies shaping the future of diabetes treatment. This episode is an essential listen for endocrinologists, diabetologists, researchers, and healthcare professionals in diabetes care looking to stay up to date with the most important technological, therapeutic, and clinical developments presented at ATTD 2026. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11–14 March 2026 in Barcelona. https://attd.kenes.com